2012 | Aarkstore.com || Bone Sarcoma - Pipeline Review, H2 2012

Document Sample
2012 | Aarkstore.com || Bone Sarcoma - Pipeline Review, H2 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Bone Sarcoma - Pipeline Review, H2 2012

http://www.aarkstore.in/Bone-Sarcoma-Pipeline-Review-H2-2012.html



Published Date : 25 September 2012
Pages : 214
PDF : $ 2000 - | Site Licence : $ 4000 | Enterprise License : $ 6000

You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Markets Direct's, Bone Sarcoma - Pipeline Review, H2 2012, provides an
overview of the indication's therapeutic pipeline. This report provides information
on the therapeutic development for Bone Sarcoma, complete with latest updates,
and special features on late-stage and discontinued projects. It also reviews key
players involved in the therapeutic development for Bone Sarcoma. Bone Sarcoma -
Pipeline Review, Half Year is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct's
team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope
- A snapshot of the global therapeutic scenario for Bone Sarcoma.
- A review of the Bone Sarcoma products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the Bone Sarcoma pipeline on the basis of route of administration and
molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Bone Sarcoma.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.

Table of Contents
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Bone Sarcoma Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Bone Sarcoma 10
Bone Sarcoma Therapeutics under Development by Companies 12
Bone Sarcoma Therapeutics under Investigation by Universities/Institutes 14
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21



List of Figures

List of Tables are also include.



More related reports:


 Multiple Sclerosis – Pipeline Review, H2 2012

 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

 Diabetes – Pipeline Review, H2 2012

 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012

 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

 Malaria – Pipeline Review, H2 2012

 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012

 Dermatitis – Pipeline Review, H2 2012

 H1N1 Infection – Pipeline Review, H2 2012

 Musculoskeletal Pain – Pipeline Review, H2 2012
Search More Reports Related to This Category :

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=H2
2012&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:0
posted:10/19/2012
language:
pages:4